Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Hokuriku TxA2 antagonist selected for evaluation

May 17, 1996

SKB discloses fibrinogen and vitronectin antagonists in patent literature

May 17, 1996

Fibrinogen antagonist from natrual source reported by Takeda

May 17, 1996

Argatroban enters phase III for HIT, HITTS

May 17, 1996

Active-site thrombin inhibitors reported by BMS

May 17, 1996

Teijin claims anticoagulant peptides

May 17, 1996

LY-329186 + aspirin effective in canine thrombosis model

May 10, 1996

Platelet antiaggregatory activity seen with Asahi's L-103

May 10, 1996

Taisho research into fibrinogen antagonists

May 10, 1996

Nippon Steel discloses anticoagulant, antithrombotic peptide

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 11, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
US lawmakers demand that Kennedy be held accountable
BioWorld
As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...